April 17, 2023
Merck and generic-drug maker Glenmark are set this week to fight multidistrict litigation claims that they gouged buyers of Merck’s blockbuster cholesterol drug Zetia by forging a pay-for-delay deal in 2010. Law360 breaks down the issues and stakes in this rare trial.
April 13, 2023
Drug buyers seeking billions in damages in an antitrust pay-for-delay trial against pharma companies Merck and Glenmark urged a D.C. federal judge Wednesday to force Covington & Burling partner Timothy Hester to livestream testimony, citing the finding of the trial's presiding judge that Hester is a "key" witness.